PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y)

Authors

  • Laura Testa Instituto do Câncer do Estado de São Paulo
  • Ruffo Freitas-Junior Universidade Federal de Goiás
  • Sergio V Serrano Hospital de Câncer de Barretos
  • Roberto J Arai Instituto do Câncer do Estado de São Paulo
  • Marina C Zorzetto Hospital de Câncer de Barretos
  • Oren Maletz Recepta Biopharma
  • Max S Mano Instituto do Câncer do Estado de São Paulo
  • Paulo M Hoff Instituto do Câncer do Estado de São Paulo

DOI:

https://doi.org/10.29289/259453942018v28s1013

Downloads

Download data is not yet available.

Author Biographies

Laura Testa, Instituto do Câncer do Estado de São Paulo

Instituto do Câncer do Estado de São Paulo – São Paulo (SP), Brazil. Hospital Sírio Libanês

Marina C Zorzetto, Hospital de Câncer de Barretos

Hospital de Câncer de Barretos – Barretos (SP), Brazil. Recepta Biopharma

Paulo M Hoff, Instituto do Câncer do Estado de São Paulo

Instituto do Câncer do Estado de São Paulo – São Paulo (SP), Brazil. Hospital Sírio Libanês

Downloads

Published

2018-06-07

How to Cite

Testa, L., Freitas-Junior, R., Serrano, S. V., Arai, R. J., Zorzetto, M. C., Maletz, O., … Hoff, P. M. (2018). PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y). Mastology, 28, 11. https://doi.org/10.29289/259453942018v28s1013

Issue

Vol. 28 (2018): Supplement 1

Section

Oral

License

Copyright (c) 2018 Laura Testa, Ruffo Freitas-Junior, Sergio V Serrano, Roberto J Arai, Marina C Zorzetto, Oren Maletz, Max S Mano, Paulo M Hoff

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.